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Objectives: Coronary artery bypass grafting (CABG) is the ‘Gold Standard’ for patients with multiple vessel coronary
artery disease (CAD). Younger patients presenting with coronary artery disease requiring surgery may represent a
distinct subgroup with the main goal for coronary revascularization being long term patency of the performed
grafts to improve outcome.
Methods: Between January 2010 and August 2013, 126 patients below the age of 50 years underwent CABG for
CAD in our hospital. We retrospectively analyzed the perioperative data and evaluated patients’ outcome.
Results: In 25% of the patients CABG was performed as an emergency procedure for STEMI or NSTEMI within
36 hours. Another 27% of the patients were operated urgently for unstable angina or myocardial infarction within
the last weeks and only 48% of the patients were purely elective cases. We performed only venous bypass grafts in
12%, total arterial revascularisation in 52% of all cases and combined venous and arterial revascularization in 43%.
Six patients needed cardiac support using an extracorporeal membrane oxygenation (Mortality n = 1 out of 6) and
17 patients received an intraaortic ballon pump perioperativly. Patients received 2.8 ± 1 bypass grafts overall. Overall
in-hospital mortality in this cohort was low with 1% (n = 1).
Conclusions: In conclusion, the majority of the young patients below the age of 50 years present urgently for
operative revascularization. Besides the potential advances regarding long term patency using total arterial
revascularization, only about half of the young patients are feasible for this approach. Overall early outcome in this
group is excellent with mortality below one percent.
Keywords: CABG, Arterial grafts, Extracorporeal life support (ECLS), Myocardial ischemia, Ischemic cardiomyopathyBackground
Coronary artery bypass grafting (CABG) remains the
Gold standard for excessive coronary artery disease in-
volving three vessels or the left main stem [1]. CABG is
more durable than percutaneous coronary intervention,
especially when using arterial grafts only [2-4]. There is
abundant literature regarding risks of elderly patients
undergoing cardiac surgery [5-7]. However, reports
about younger patients undergoing CABG are sparse.
D’Errigo et al. recently reported the multicenter data
concerning patients below 50 years of age receiving
CABG with a mortality rate of 0.9% overall [8]. However,
no details about the used grafts were given in that study.
A low postoperative mortality rate has also been reported* Correspondence: Fleissner.Felix@mh-hannover.de
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by percutaneous coronary intervention (0.86%). How-
ever, percutaneous coronary interventions were per-
formed in 41% of cases in patients with single vessel
coronary artery disease, which is significantly different
from surgical series [8].
Patients who would benefit most from prolonged
patency of total artery revascularization are the young
patients. In this study we therefore sought to further
evaluate patients under the age of 50 years receiving cor-
onary artery bypass grafting.Methods
We retrospectively analysed all consecutive patients below
the age of 50 years receiving CABG at our clinic from
January 2010 until August 2013. The Ethics Committee of
Hanover Medical School approved this study. Informedl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of this report.
Operative technique
A full median sternotomy was performed (except one
patient receiving an upper hemisternotomy due to a high
grade stenosis of the right coronary artery of anomalous
origin). We used cardiopulmonary support in most cases
(n = 125), except for the patient receiving the upper
hemisternotomy.
Total arterial revascularization (TAR)
After a full median sternotomy the LITA was harvested
in no touch technique with minimal trauma as pedicled
graft and treated with papaverine solution prior to use.
RA was harvested from the non-dominant arm. We per-
formed duplex sonography to assure open palmar arches.
The T-graft was performed prior to initiating CPB be-
tween the RA and the LITA using an 8–0 prolene suture.
CBP was initiated after completion of the T graft.
Combined venous and arterial revascularization
We usually used the LITA and the saphenous vein as
grafts. The LITA was most frequently anastomosed to
the LAD or D1, whereas the saphenous vein was used
for up to three sequential anastomoses. The venous only
revascularization was achieved using the saphenous vein
as aortocoronary bypass anastomosed to the acending
aorta as standardized.
CPB was instituted with cannulation of the ascending
aorta and a single two-stage right atrial cannulation.
Standard bypass management included membrane oxy-
genators, arterial line filters, and non-pulsatile flow (or
pulsatile flow for patients kidney failure) with a mean ar-
terial pressure greater than 50 mm Hg. The myocardium
was protected by using intermittent antegrade cold
blood cardioplegia or crystalloid solution. Anticoagula-
tion was achieved using 300 U/kg of heparin. If required,
heparin was supplemented to maintain the activated
clotting time above 450 s and was fully reversed with
protamine at the end of the procedure. Patients received
intravenous nitroglycerin infusions for the first 24 h if
feasible. Inotropic agents were chosen by the haemo-
dynamic state. Other routine medications included daily
aspirin (300mg Aspirin i.v. 6 hour postoperatively unless
bleeding occurred, 100mg Aspirin p.o. the first postoper-
ative day) and resumption of cholesterol-lowering agents
and β-blockers unless contraindicated beginning during
the early postoperative course.
Statistical analysis
Statistical analysis was performed using SPSS 22 package
(SPSS Inc, Chicago, Il, USA). The data were shown as
mean ± SD. Comparison of groups was performed usingunpaired t-test or ANOVA with statistical significance
assumed for p values <0.05.
Results
Patients
A total of 126 CABG cases in patients below the age of
50 years were performed. Twenty five percent (n = 30) of
the operations were emergencies, Twenty seven percent
(n = 35) of the patients were operated urgently and only
48% (n = 61) of the patients were elective cases. 52 pa-
tients recently had a myocardial infarction (<30 days) of
which 18 patients presented with myocardial infarction
under 12 hours prior to the operation.
Median age was 46.98 (range from: 24–49), 81% (n = 102)
of the patients were male. Patients usually presented with
multiple risk factors. Arterial hypertension was present in
77%, nicotine abuse in 79% and hyperlipidaemia in 71% of
patients. Obesity was present in 34% of cases, diabetes
mellitus in 25% of cases and a familial pre-disposition
was reported in only 20% of cases. The overall pre-
operative left ventricular ejection fraction (LV-EF) was
55.5% (±13.8%). However, 12% of patients presented
with a poor LV-EF below 35%. Only two patients were
cardiac re-dos (one AVR and one CABG). Nine patients
recently underwent CPR in the pre-operative course
due to ventricular fibrillation. 36 Patients had already
undergone PTCA/Stent implantation before they were
admitted to cardiac surgery.
Of these 36 patients who received an intervention
prior to CABG, 3 patients presented with iatrogenic
dissections in the target vessels and were subsequently
referred to CABG, 4 patients had undergone an unsuc-
cessful PCI attempt in one or two target vessels prior
to referral to operative revascularization. 10 patients
presented with in-stent re-(re) stenosis in stented vessels.
Only one patient received a PCI (without stent implant-
ation) of the culprit lesion (RPLA) directly prior to surgery
as a bridging therapy to surgical revascularization in acute
myocardial infarction (STEMI). One patient was reani-
mated extrahospitally and received a lysis therapy. The
patient received a coronary angiogram after admission to
the hospital which showed a 3 vessel disease. Another pa-
tient with an iatrogenic dissection of the LAD received
ReoPro directly prior to operation as a rescue attempt.
66% (n = 83) of patients were symptomatic prior to the
operation (NSTEMI, STEMI and unstable angina).
Six patients presented with severe mitral valve regur-
gitation du to ischemic papillary muscle rupture. 12
Patients had renal insufficiency preoperatively, of those
3 patients were on dialysis. For further pre-operative de-
tails, please refer to Table 1.
Operation, cardiopulmonary bypass and clamp times
were 203.96 ± 58.51 min 88.70 ± 39.97 min and 49.95 ±
22.63 min, respectively. ICU stay and overall hospital
Table 1 Patient’s characteristics
Patient’s characteristics:
Age, years 46.98 (range from: 24–49)
Sex, male (%) 102 (81)
Left ventricular ejection fraction
in % (± SD)
55.5 (±13.8)
Poor LV-EF (35% or below) 15 (12)
Creatinine (± SD) 85.6 (±66.9)
CK U/l (± SD) 375.9 (±1072)
CK-MB U/l (± SD) 45.4 (±96.1)
Pre-op renal insufficiancy (%) 12 (10)
Pre-op dialysis (%) 3 (2)
Arterial hypertension (%) 97 (77)
Nicotine abuse (%) 99 (79)
Hyperlipidaemia (%) 89 (71)
Diabetes mellitus (%) 25 (20)
Obesity (%) 43 (34)
Emergency (%) 30 (25)
Urgent (%) 35 (27)




Recent STEMI (%) 25 (20)
Unstable angina (%) 33 (26)
Stable angina (%) 43 (34)






Cardiac Re-do 2 (2)
Continuous variables are presented with the standard deviation or median with
range (age), categoric variables are presented as number (%).
LV-EF (Left-ventricular ejection fraction), CK (creatinine kinase), CK-MB
(muscle-brain creatinine kinase), STEMI (ST-elevation myocardial infarction),
IABP(intraaortic ballon pump), ECLS (Extracorporal Life Support System), PTCA
(percutaneous transluminal coronary angioplasty).
Table 2 Operative data
Operative data:
Operation time min (± SD) 203.96 (±58.51)
Cardiopulmonary bypass times min (± SD) 88.71 (±39.97)
Clamp times min (± SD) 45.95 (±22.63)
Of-pump procedures 1 (1)
Venous bypass grafts (exclusivly) 15 (12)
Total arterial revascularization 66 (52)
Arterial and venous revascularization 43 (34)
Number of performed bypass grafts n (± SD) 2.87 (±0.92)
Concomittant procedures
Mitral valve repair 3
Mitral valve replacement 3
Aortic valve replacement 1
DOR Plasty 3
Carotid TEA 1
Continuous variables are presented with the standard deviation; categoric
variables are presented as number (%). Carotid TEA (thromboendarterectomy).
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ively (See Table 2). In-hospital and 30 day mortality was
0.9% (n = 1). Six patients needed Extracorporal Life
Support System (ECLS) (See Table 3) and 17 patients
received peri-operative intraaortic ballon pump (IABP)
support. One patient died during postoperative course.
This patient presented in cardiogenic shock due to
STEMI, was switched from IABP support to ECLS sup-
port and died during post-operative course despite all
efforts in multi-organ failure. Retrospectively, this pa-
tient might have benefited from initial ECLS support
instead of IABP support. The other five patients could
be weaned successfully from ECLS support. Concomitant
procedures included mitral valve repair or replacement insix patients. One patient received an aortic valve replace-
ment due to severe aortic insufficiency and one patient re-
ceived a carotid endarterectomy. Three patients received a
DOR plasty due to left ventricular aneurysms.
The left internal thoracic artery (LITA) was used in 111
cases (88%) and either anastomosed to the LAD, LAD and
D1, or to the RIM. The right internal thoracic artery
(RITA) was used in 8 cases (6%). The radial artery (RA) as
a T-graft was used in 51 cases and as a free graft in two
cases. In total, the RA was used in 53 cases (42%).
In case of a total arterial revascularisation, combined
venous and arterial revascularisation and venous revascu-
larisation only, 2.6 (±0.89), 3.19 (±0.93) and 2.75 (±1.39)
bypass grafts were anastomosed, respectively.
We performed venous bypass grafts in 12% (n = 15),
total arterial revascularisation (using mainly the left
internal thoracic artery with the radial artery as T-graft)
in 52% (n = 62) of all cases and combined venous and ar-
terial revascularization in 43% (n = 34).
Total arterial revascularisation was performed in 68%
of elective cases. Urgent cases received total arterial
revascularisation in 57% of cases. However, the emergent
cases were suitable for total arterial revascularisation in
17% of cases. Accordingly, combined venous and arterial
revascularisations in elective, urgent and emergency op-
erations were 26%, 37% and 50%, respectively (See also
Figure 1).
Postoperative course included two patients with a pul-
monary embolism and one patient with a peri-operative
stroke. Incidentally, the patient who suffered from stroke
intra-operatively had an undiagnosed atrial septum de-
fect (ASD), despite pre-operative echocardiography, and
received an ASD closure during a later hospital stay after
Table 3 ECLS subgroup analysis
Patient Presentation Indication for ECLS ECLS support Surgery Postoperative course Outcome
1 NSTEMI, CA: Bifurcation stenosis of LAD/D1 difficult weaning from CPB d0-d2 LIMA-LAD,-D1 ECMO explanation D3, uneventful
postoperative course
LV-EF at discharge 50%
2 Present to referring hospital with angina,
CA: RCA 100%, CX: procimal 90%, LAD; 100%,
unsuccessful attempt for PTCA/Stentimplantation
of the CX with iatrogenic dissection, rescue
attempt with ReoPro, CPR during postoperative
course, operation the same day as admission
to primary hospital
difficult weaning from CPB




dialysis during postoperative course,
recovered POD 17, prolonged ventilation
with tracheotomy, removed POD 23,
Re-Thoracotomy POD 1, POD 12 due to
haematothorax with pericardial tamponade
LV-EF POD 1: 20% under
ECLS support), LV-EF prior
to discharge: 50%
3 STEMI, CA: LAD 100% proximal, CX, PLA 1 90%,
RCA 100%, Patient in cardiogenic shock with
unstable hameodynamic under catecholamines,
immediate referral to OR
cardiogenic shock, difficult




dialysis during postoperative course,
recovery day 14,
LV-EF POD 1 under ECLS
25%, LV-EF prior to
discharge 35%
4 Unstable angina, CA: LAD 90%, Cx 100%, RCA
100%, cardiac decompensation with peripheral
oedema and septic ulcers, multiple sclerosis,
severe obesity
cardiogenic shock, difficult




(septic ulcers, no vein
grafts available)
Dialysis during postoperative course,
compartment syndrome left lower leg,
re-thoracotomy due to tamponade,
septic shock
death POD 7
5 presentation with beginning cardiac
decompensation and respiratory insufficiency,
CA: LAD 100%, Cx 90, RCA 90%, ECLS support
in reffering hospital prior to transport, Echo:
LV-EF 45%, MI III (rupture of posteromedian
papillary muscle)
cardiogenic shock d-1-d4 MVR (SJM, 29 mm),
ACVB-LAD, ACVB-
PLA1-RIVP
Dialysis during postoperative course,
recovered POD 5, short CPR on POD 5,
ICD implantation POD 30
LV-EF at discharge 65%
mechanical prosthesis in
mitral position with no
PVL and normal function
6 Angina and Dyspnoea in referring hospital,






Dialysis once (POD 1), prolonged
ventilation with tracheotomy until
POD 27
LV-EF prior to discharge
40%
Clinical presentation, performed surgery, postoperative course and outcome of the six patients requiring ECLS. ECLS (Extracorporal Life Support System) NSTEMI (Non-ST-Elevated Myocardial Infarction), STEMI (ST-elevation














































Figure 1 Flow chart of the 126 pts. receiving coronary artery bypass grafting. TAR: total artery revascularisation, A + V: combined venous and
arterial revascularisation, V: venous grafts only.
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needed prolonged ventilatory support (>48 h) and six
patients developed a transient kidney insufficiency post-
operatively (See Table 4).
Three patients needed a revision of their bypass grafts
after suffering from postoperative myocardial infarction,
and three patients needed revision due to symptomatic
bleeding with either a haematothorax (n = 2) or pericardial
tamponade (n = 1). One of the patients with postoperative
bleeding had undergone a rescue attempt using Abcixi-
mab (ReoPro) in the cath lab due to an iatrogenic dissec-
tion of the LAD directly prior to operation. Seven patients
were re-administered after recovery for removal of the
sternal cerclages, all due to pain during movement.Discussion
Despite all advances in prevention and diagnostics, as
well as general awareness for cardiovascular disease in
the elderly, our patient collective with young patients
below 50 years of age often present in urgent orTable 4 Postoperative course
Re-Thoracotomy 6 (5)
Bleeding 3 (2)
Respiratory insufficiancy 10 (8)
Postoperative renal insufficiancy 6 (5)
Stroke 1 (1)
Postop coronary angiogram (unplanned) 3 (2)
Secondary thoracic operations 9 (7)
Post-op left ventricular ejection fraction in % (± SD) 56.83 (±12.13)
In hospital death 1 (1)
Revision of bypass grafts 3 (2)
Continuous variables are presented with the standard deviation; categoric
variables are presented as number (%).emergency settings. We have to assume that especially
in these young patients with multiple risk factors; diag-
nosis of a coronary artery disease is delayed because of
inadequate awareness. Clinical presentation of our pa-
tients collective was rather heterogeonus which makes a
direct, propensity matched comparison very difficult. Es-
pecially the high frequency of extra hospital reanimated
patients and patients with iatrogenic complications during
PCI, makes a comparison to previous published studies
for CABG difficult.
Although the recent long-term results from the SYNTAX
[1], ASCERT [9], and FREEDOM [10] trials showed sig-
nificantly better survival rates after CABG than after PCI,
CABG rates are declining over the past years, while PCI
rates increase accordingly [11]. Nonetheless, CABG re-
mains the Gold Standard for patients with coronary artery
disease including those with diabetes and/or complex left
main or three-vessel disease [1,9].
The technique of CABG has not changed significantly
over the past years. However, the use of bypass material
remains under intense discussion. The use of one internal
thoracic artery as graft, most often the LITA anastomosed
to the LAD combined with venous conduits represents
the standard therapy for patients undergoing CABG [12].
Failure rates of up to 12% of saphenous vein grafts
within the first week after operation have been described.
Therefore alternative grafts such as bilateral internal thor-
acic artery or radial artery grafts are more frequently used.
The long-term results from recent trials suggest favor-
able radial artery graft patency rates over saphenous vein
grafts [13,14]. Accordingly, several large observational
studies have confirmed excellent graft patency and have
reported superior long-term survival rates, [15] also after
applying propensity matching [4,16] for patients receiv-
ing the radial artery as bypass grafts. However, concerns
regarding vessel spasm, graft atherosclerosis, and un-
favorable results from a number of studies exist. We do
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standard graft in patients with no contraindications against
this approach.
While these young patients would benefit most from a
total arterial revascularization given its superior long termFigure 2 Factual decision making for graft selection in Coronary artery byp
Support System) ACS (Acute Coronary Syndrome), STEMI (ST-elevation myo
ejection fraction), LMCA (Left main coronary artery).patency rates [4,13-16], this approach is frequently not
possible. In our series, 57% of urgent and 17% of emer-
gency cases received a TAR in the subgroup analysis.
In our case series, 12% of patients present with a left ven-
tricular ejection fraction of 35% or lower. This underlinesass grafting especially in younger patients. ECLS (Extracorporal Life
cardial infarction), IABP (intraaortic ballon pump), LV-EF (Lef-ventricular
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to the hospital in a later stage of their disease.
However, the possible long-term advantage of a TAR is
diminished by the fact that the life expectancy of these
ill patients is severely diminished. Although, the options
for a patient requiring CABG are small (TAR, venous
and arterial revascularization, venous revascularization
only) the decision making process is rather complex (see
Figure 2). In general we agree that absolute contraindi-
cations for a TAR are: cardiogenic shock, expected high
doses of postoperative catecholamines and a life expect-
ancy of less then 10 years. Graft availability is sometimes
limited, too. Especially patients requiring dialysis prior
to operation or patients that will require dialysis in
the future might, the use of the LITA or RITA is for-
bidden for sake a cimino fistula. Chronic obstructive
lung disease, if severe, might lead to the use of ven-
ous grafts only to keep the pleura closed. None the
less, we are less concerned about the age of the pa-
tient since the use of radial artery grafts for revascu-
larization not only leads to better graft patency rates,
however graft harvesting site related complications are
also quite rare, and less frequent then with the use of sa-
phenous vein grafts.
Emergency operations, as well as an impaired left ven-
tricular function (below 35% LV-EF) are relative contrain-
dications for a total arterial revascularization. Urgent
cases with stable haemodynamics might or might not re-
ceive TAR. The usage of TAR in cases of left main coron-
ary artery stenosis (LMCA) is currently under discussion.
However, LMCA stenosis is only a relative contraindica-
tion for TAR at our department and underlies the sur-
geon’s discretion.
We also found these patients to be prone for compli-
cations, and re-operation rates were relatively high, espe-
cially those for removal of sternal cerclages. This could
be in fact due to a more active lifestyle of this patient
collective. None of these were secondary operations
were due to sternal wound infections. In fact, the wound
complication rate in this collective was very low. This
might be due to the low rate of diabetics, a disease primar-
ily of the elderly patient.
In general our low postoperative mortality rate is simi-
lar to that reported by Khawaja et al. [17]. Available data
about the postoperative morbidity of young CABG pa-
tients report 94% of patients aged <50 years undergoing
CABG recovering without any major events and 96% of
patients being discharged to home [8].
Conclusions
Findings prove that surgical revascularization for co-
ronary artery disease can be performed with very low
mortality in young patients. However, presentation of
patients with high rates of emergency and urgent casesoften hinder the favourable approach of total arterial
revascularization.
Limitations
A limitation of this study is the lack of data on long-term
outcome. Comparative studies evaluating the immediate
and late outcome studies are needed to further refine the
strategy of revascularization in young patients receiving
CABG.
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